Tumor agnostic in Oncology
Tumor-agnostic therapies represent a paradigm shift in how we understand and treat cancers
This website comprises scientific information about tumor agnostic approaches in Oncology.
The genetic etiology of a wide variety of cancers lead to the development of genomically-informed treatment strategies targeting molecular alterations regardless of histological origin. Underlying molecular markers for tumor agnostic in Oncology usually fulfill the following criteria:
Alterations are found across a variety of cancers.
Alterations are likely to predict response to a therapy
Within this hub, you will find information about the concept of tumor agnostic in Oncology including recent publications and congress updates.
